Pelthos Therapeutics Statistics
Total Valuation
PTHS has a market cap or net worth of $93.26 million. The enterprise value is $142.18 million.
| Market Cap | 93.26M |
| Enterprise Value | 142.18M |
Important Dates
The last earnings date was Thursday, August 13, 2026, before market open.
| Earnings Date | Aug 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
PTHS has 3.83 million shares outstanding. The number of shares has increased by 435.44% in one year.
| Current Share Class | 3.83M |
| Shares Outstanding | 3.83M |
| Shares Change (YoY) | +435.44% |
| Shares Change (QoQ) | +6.84% |
| Owned by Insiders (%) | 8.47% |
| Owned by Institutions (%) | 27.59% |
| Float | 1.42M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.15 |
| Forward PS | 1.10 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 3.28 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.98
| Current Ratio | 1.98 |
| Quick Ratio | 1.21 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -7.46 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -49.98% |
| Return on Invested Capital (ROIC) | -102.45% |
| Return on Capital Employed (ROCE) | -52.42% |
| Weighted Average Cost of Capital (WACC) | 15.29% |
| Revenue Per Employee | $470,696 |
| Profits Per Employee | -$939,043 |
| Employee Count | 92 |
| Asset Turnover | 0.63 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -7.39M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +8.46% in the last 52 weeks. The beta is 3.05, so PTHS's price volatility has been higher than the market average.
| Beta (5Y) | 3.05 |
| 52-Week Price Change | +8.46% |
| 50-Day Moving Average | 26.87 |
| 200-Day Moving Average | 25.55 |
| Relative Strength Index (RSI) | 40.99 |
| Average Volume (20 Days) | 44,935 |
Short Selling Information
The latest short interest is 96,528, so 2.52% of the outstanding shares have been sold short.
| Short Interest | 96,528 |
| Short Previous Month | 70,670 |
| Short % of Shares Out | 2.52% |
| Short % of Float | 6.81% |
| Short Ratio (days to cover) | 1.04 |
Income Statement
In the last 12 months, PTHS had revenue of $43.30 million and -$86.39 million in losses. Loss per share was -$26.36.
| Revenue | 43.30M |
| Gross Profit | 32.73M |
| Operating Income | -55.25M |
| Pretax Income | -93.78M |
| Net Income | -86.39M |
| EBITDA | n/a |
| EBIT | -55.25M |
| Loss Per Share | -$26.36 |
Balance Sheet
The company has $24.19 million in cash and $73.11 million in debt, with a net cash position of -$48.92 million or -$12.78 per share.
| Cash & Cash Equivalents | 24.19M |
| Total Debt | 73.11M |
| Net Cash | -48.92M |
| Net Cash Per Share | -$12.78 |
| Equity (Book Value) | -1.50M |
| Book Value Per Share | -0.40 |
| Working Capital | 31.40M |
Cash Flow
In the last 12 months, operating cash flow was -$42.30 million and capital expenditures -$295,000, giving a free cash flow of -$42.60 million.
| Operating Cash Flow | -42.30M |
| Capital Expenditures | -295,000 |
| Depreciation & Amortization | 1.69M |
| Net Borrowing | 44.64M |
| Free Cash Flow | -42.60M |
| FCF Per Share | -$11.13 |
Margins
Gross margin is 75.58%, with operating and profit margins of -127.60% and -199.50%.
| Gross Margin | 75.58% |
| Operating Margin | -127.60% |
| Pretax Margin | -216.56% |
| Profit Margin | -199.50% |
| EBITDA Margin | n/a |
| EBIT Margin | -127.60% |
| FCF Margin | n/a |
Dividends & Yields
PTHS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -435.44% |
| Shareholder Yield | -435.44% |
| Earnings Yield | -92.63% |
| FCF Yield | -45.67% |
Analyst Forecast
The average price target for PTHS is $53.14, which is 118.14% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $53.14 |
| Price Target Difference | 118.14% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (3Y) | 111.65% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on July 2, 2025. It was a reverse split with a ratio of 1:10.
| Last Split Date | Jul 2, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
PTHS has an Altman Z-Score of -1.57 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.57 |
| Piotroski F-Score | 2 |